Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¶±â¼º ÇǺμ¶À¯À°Á¾¿¡¼­ ÁøÇàÇÑ ¾Ç¼º ¼¶À¯Á¶Á÷±¸Á¾ Progression of Dermatofibrosarcoma Proruberans to Malignant Fibrous Histiocytorna

´ëÇѺ´¸®ÇÐȸÁö 1997³â 31±Ç 12È£ p.1324 ~ 1327
¹ÚÇý¸², Á¤ÀºÇÏ, À¯È«¼º,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÇý¸² (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Á¤ÀºÇÏ (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À¯È«¼º (  ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

À¶±â¼º ÇǺμ¶À¯À°Á¾Àº ÁߵÀÇ ¾Ç¼ºµµ¸¦ º¸ÀÌ´Â ¼¶À¯Á¶Á÷±¸¼º Á¾¾çÀ¸·Î µå¹°°Ô À°Á¾°ú
À¯»çÇÑ ºÎÀ§¸¦ Á¾¾çÀÇ ÀϺο¡¼­ °üÂûÇÒ ¼ö ÀÖ°í, ÀÌ´Â Àç¹ß¼º º´º¯¿¡¼­ ÁÖ·Î °üÂûµÈ´Ù. ƯÈ÷
À¶±â¼º ÇǺμ¶À¯À°Á¾¿¡¼­ ¾Ç¼º ¼¶À¯Á¶Á÷±¸Á¾À¸·Î ÁøÇàµÇ´Â °ÍÀº ±ØÈ÷ µå¹°¾î ÇöÀç±îÁö ¿µ¹®
¹®Çå»ó ´ÜÁö 3¿¹ÀÇ Áõ·Ê¸¸ÀÌ º¸°íµÇ¾î ÀÖ´Ù. ÀúÀÚµéÀº ÃÖ±Ù À¶±â¼º ÇǺμ¶À¯À°Á¾À¸·Î Áø´Ü
¹Þ°í 10³âÈÄ °°Àº ºÎÀ§¿¡ Àç¹ßÇÑ Á¾¾çÀº ¾Ç¼º ¼¶À¯Á¶Á÷±¸Á¾À¸·Î ÁøÇàµÈ 1¿¹¸¦ °æÇèÇÏ¿© ±×
Èñ±Í¼º¿¡ ºñÃß¾î º¸°íÇÔ°ú µ¿½Ã¿¡ CD34¿¡ ´ëÇÑ ¸é¿ªÁ¶Á÷È­ÇÐ °Ë»ç¸¦ ÅëÇÏ¿© ±× Á¶Á÷±â¿ø¿¡
´ëÇÑ ¹®Çå°íÂû°ú ÇÔ²² Áõ·Ê¸¦ º¸°íÇÏ°íÀÚ ÇÑ´Ù.
#ÃÊ·Ï#
A 52-year-old woman was admitted with a palpable mass on the abdominal wall.
This tumor had developed at the same site of a previously resected dermatofibrosarcoma
protuberans. The biopsy specimen from the recurrent tumor revealed malignant fibrous
histiocytoma. Immunohistochemistry with anti-CD34 antibody revealed diffuse linear
positivity on the tumor cells of dermatofibrosarcoma protuberans and negativity on
malignant fibrous histiocytoma. Anti CD34 antibody was valuable for a differential
diagnosis of these two lesions.

Å°¿öµå

Dermatofibrosarcoma protuberans; Malignant fibrous histiocytoma; CD34;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS